J Neurol Surg B Skull Base 2020; 81(06): 627-637
DOI: 10.1055/s-0039-1694050
Original Article

Treatment of Sinonasal Adenocarcinoma: A Population-Based Prospective Cohort Study

1   Department of Neurosurgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway
2   Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
,
Terje Osnes
2   Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
3   Department of Otorhinolaryngology, Head and Neck Surgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway
,
Åse Bratland
4   Department of Oncology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
,
Peter Jebsen
5   Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
,
Torstein R. Meling
1   Department of Neurosurgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway
2   Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
6   Service de Neurochirurgie, Département des Neurosciences Cliniques, Hopitaux Universitaires de Genève, Geneva, Switzerland
7   Faculty of Medicine, University of Geneva, Geneva, Switzerland
› Author Affiliations

Abstract

Objectives Sinonasal adenocarcinoma (AC) is a potentially curable disease despite being an aggressive malignancy. Long-term survival can be achieved with early diagnosis and adequate multidisciplinary treatment. Our goal was to evaluate outcomes for patients with AC treated at our institution.

Design In a population-based consecutive prospective cohort, we conducted an analysis of all patients treated for surface epithelial AC between 1995 and 2018.

Results Twenty patients were included, and follow-up was 100%. The mean follow-up time was 89 months for the entire cohort (112 months for patients with no evidence of disease). Intestinal-type AC was found in 65%, whereas nonintestinal-type AC was found in 35% of all cases; 75% had stage T3/4 disease. Tumor grade was intermediate/high in 65%. Eighteen patients underwent treatment with curative intent (craniofacial resection [CFR] in 61%, transfacial approach in 39%, adjuvant radiotherapy in 89%), achieving negative margins in 56% of cases. Overall survival (OS) rates were 90, 68, and 54% after 2, 5, and 10 years of follow-up, respectively, and the corresponding disease-specific survival (DSS) rates were 90, 73, and 58%. Age over 60 years, tumor with a maxillary origin, and microscopic bone invasion were negative prognostic factors. Radical CFR was correlated with better OS and DSS.

Conclusion The high probability of achieving radicality with CFR, the low complication rate, the acceptable toxicity of modern irradiation modalities, and the promising survival rates indicate that this strategy might be considered a safe and an effective option for treating patients with very advanced sinonasal AC.

Ethical Approval

This study was approved by the data protection official at OUH (ePhorte 2015–5042). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study does not contain any studies with animals performed by any of the authors.


Informed Consent

For this type of study, formal consent is not required.




Publication History

Received: 06 February 2019

Accepted: 11 June 2019

Article published online:
30 July 2019

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Lund VJ, Stammberger H, Nicolai P. et al; European Rhinologic Society Advisory Board on Endoscopic Techniques in the Management of Nose, Paranasal Sinus and Skull Base Tumours. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 2010; 22: 1-143
  • 2 Myers LL, Nussenbaum B, Bradford CR, Teknos TN, Esclamado RM, Wolf GT. Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope 2002; 112 (11) 1964-1969
  • 3 Waldron J, Witterick I. Paranasal sinus cancer: caveats and controversies. World J Surg 2003; 27 (07) 849-855
  • 4 Llorente JL, Pérez-Escuredo J, Alvarez-Marcos C, Suárez C, Hermsen M. Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review. Eur Arch Otorhinolaryngol 2009; 266 (01) 1-7
  • 5 Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F. Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 2013; 24 (01) 39-49
  • 6 Leivo I. sinonasal adenocarcinoma: update on classification, immunophenotype and molecular features. Head Neck Pathol 2016; 10 (01) 68-74
  • 7 Jankowski R, Georgel T, Vignaud JM. et al. Endoscopic surgery reveals that woodworkers' adenocarcinomas originate in the olfactory cleft. Rhinology 2007; 45 (04) 308-314
  • 8 Thompson LD, Penner C, Ho NJ. et al. Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases. Head Neck Pathol 2014; 8 (01) 88-109
  • 9 Bhaijee F, Carron J, Bell D. Low-grade nonintestinal sinonasal adenocarcinoma: a diagnosis of exclusion. Ann Diagn Pathol 2011; 15 (03) 181-184
  • 10 Batsakis JG, Rice DH, Solomon AR. The pathology of head and neck tumors: squamous and mucous-gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surg 1980; 2 (06) 497-508
  • 11 Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986; 10 (03) 192-202
  • 12 Kleinsasser O, Schroeder HG. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch Otorhinolaryngol 1988; 245 (01) 1-15
  • 13 Franchi A, Santucci A, Wenig BM. Adenocarcinoma. World Health Organization Classification of Tumours, Pathology and Genetics, Head and Neck Tumours. Lyon: IARC Press; 2005
  • 14 Franchi A, Miligi L, Palomba A, Giovannetti L, Santucci M. Sinonasal carcinomas: recent advances in molecular and phenotypic characterization and their clinical implications. Crit Rev Oncol Hematol 2011; 79 (03) 265-277
  • 15 Acheson ED, Hadfield EH, Macbeth RG. Carcinoma of the nasal cavity and accessory sinuses in woodworkers. Lancet 1967; 1 (7485): 311-312
  • 16 Imbus HR, Dyson WL. A review of nasal cancer in furniture manufacturing and woodworking in North Carolina, the United States, and other countries. J Occup Med 1987; 29 (09) 734-740
  • 17 Ironside P, Matthews J. Adenocarcinoma of the nose and paranasal sinuses in woodworkers in the state of Victoria, Australia. Cancer 1975; 36 (03) 1115-1124
  • 18 Leclerc A, Luce D, Demers PA. et al. Sinonasal cancer and occupation. Results from the reanalysis of twelve case-control studies. Am J Ind Med 1997; 31 (02) 153-165
  • 19 Moran CA, Wenig BM, Mullick FG. Primary adenocarcinoma of the nasal cavity and paranasal sinuses. Ear Nose Throat J 1991; 70 (12) 821-828
  • 20 IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. International Agency for Research on Cancer. Chemicals, Industrial Processes, and Industries Associated with Cancer in Humans: IARC Monographs. Volumes 1–29. Lyon: International Agency for Research on Cancer; 1982
  • 21 Lund VJ, Howard DJ, Wei WI, Cheesman AD. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses--a 17-year experience. Head Neck 1998; 20 (02) 97-105
  • 22 Heffner DK, Hyams VJ, Hauck KW, Lingeman C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer 1982; 50 (02) 312-322
  • 23 Lund VJ. Malignancy of the nose and sinuses. Epidemiological and aetiological considerations. Rhinology 1991; 29 (01) 57-68
  • 24 Lund VJ, Harrison DF. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses. Am J Surg 1988; 156 (3 Pt 1): 187-190
  • 25 König M, Osnes T, Jebsen P, Evensen JF, Meling TR. Olfactory neuroblastoma: a single-center experience. Neurosurg Rev 2018; 41 (01) 323-331
  • 26 König M, Osnes T, Jebsen P, Meling TR. Craniofacial resection of malignant tumors of the anterior skull base: a case series and a systematic review. Acta Neurochir (Wien) 2018; 160 (12) 2339-2348
  • 27 König M, Osnes TA, Lobmaier I. et al. Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years. Neurosurg Rev 2017; 40 (03) 449-460
  • 28 Katz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 2002; 24 (09) 821-829
  • 29 Bridgeman AM, Murphy MJ, Sizeland A, Wiesenfeld D. Midfacial tumours: a review of 72 cases. Br J Oral Maxillofac Surg 2000; 38 (02) 94-103
  • 30 Jun BC, Song SW, Park CS, Lee DH, Cho KJ, Cho JH. The analysis of maxillary sinus aeration according to aging process; volume assessment by 3-dimensional reconstruction by high-resolutional CT scanning. Otolaryngol Head Neck Surg 2005; 132 (03) 429-434
  • 31 de Gabory L, Maunoury A, Maurice-Tison S. et al. Long-term single-center results of management of ethmoid adenocarcinoma: 95 patients over 28 years. Ann Surg Oncol 2010; 17 (04) 1127-1134
  • 32 Amin MB, Greene FL, Edge SB. et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017; 67 (02) 93-99
  • 33 Zange J, Schuchardt K. Rhinologische und plastiche Operationen auf Grenzgebieten mit der Ophthalmologie und Chirurgie. In: Thiel R. ed. Ophthalmologische Operationslehre. Leipzig: Thieme; 1950: 1302
  • 34 Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
  • 35 Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50 (03) 163-170
  • 36 Cox D. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220
  • 37 Fisher RA. On the interpretation of X2 from contingency tables, and the calculation of P. J R Stat Soc 1922; 85 (01) 87-94
  • 38 Danish Head and Neck Cancer Group (DAHANCA). https://www.dahanca.dk/ . Accessed February 1, 2018
  • 39 Bernier J, Domenge C, Ozsahin M. et al; European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350 (19) 1945-1952
  • 40 Choussy O, Ferron C, Védrine PO. et al; GETTEC Study Group. Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope 2008; 118 (03) 437-443
  • 41 Dulguerov P, Allal AS. Nasal and paranasal sinus carcinoma: how can we continue to make progress?. Curr Opin Otolaryngol Head Neck Surg 2006; 14 (02) 67-72
  • 42 Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92 (12) 3012-3029
  • 43 Orvidas LJ, Lewis JE, Weaver AL, Bagniewski SM, Olsen KD. Adenocarcinoma of the nose and paranasal sinuses: a retrospective study of diagnosis, histologic characteristics, and outcomes in 24 patients. Head Neck 2005; 27 (05) 370-375
  • 44 Michel J, Radulesco T, Penicaud M, Mancini J, Dessi P. Sinonasal adenocarcinoma: clinical outcomes and predictive factors. Int J Oral Maxillofac Surg 2017; 46 (04) 422-427
  • 45 Gras-Cabrerizo JR, Montserrat-Gili JR, León-Vintró X, Massegur-Solench H, de Vega JM, Virós-Porcuna D. Treatment results for ethmoid sinus carcinoma. J Laryngol Otol 2009; 123 (10) 1120-1124
  • 46 Bhayani MK, Yilmaz T, Sweeney A. et al. Sinonasal adenocarcinoma: a 16-year experience at a single institution. Head Neck 2014; 36 (10) 1490-1496
  • 47 Cantù G, Bimbi G, Miceli R. et al. Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment. Arch Otolaryngol Head Neck Surg 2008; 134 (02) 170-177
  • 48 Wood dust. IARC Monogr Eval Carcinog Risks Hum 1995; 62: 35-215
  • 49 Schwaab G, Julieron M, Janot F. Epidemiology of cancers of the nasal cavities and paranasal sinuses [in Italian]. Neurochirurgie 1997; 43 (02) 61-63
  • 50 Brinton LA, Blot WJ, Becker JA. et al. A case-control study of cancers of the nasal cavity and paranasal sinuses. Am J Epidemiol 1984; 119 (06) 896-906
  • 51 Bonneterre V, Deschamps E, Persoons R. et al. Sino-nasal cancer and exposure to leather dust. Occup Med (Lond) 2007; 57 (06) 438-443
  • 52 Demers PA, Kogevinas M, Boffetta P. et al. Wood dust and sino-nasal cancer: pooled reanalysis of twelve case-control studies. Am J Ind Med 1995; 28 (02) 151-166
  • 53 Kauppinen T, Vincent R, Liukkonen T. et al. Occupational exposure to inhalable wood dust in the member states of the European Union. Ann Occup Hyg 2006; 50 (06) 549-561
  • 54 Holmila R, Bornholdt J, Heikkilä P. et al. Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer. Int J Cancer 2010; 127 (03) 578-588
  • 55 Cantu G, Solero CL, Mariani L. et al. Intestinal type adenocarcinoma of the ethmoid sinus in wood and leather workers: a retrospective study of 153 cases. Head Neck 2011; 33 (04) 535-542
  • 56 Projetti F, Durand K, Chaunavel A. et al. Epidermal growth factor receptor expression and KRAS and BRAF mutations: study of 39 sinonasal intestinal-type adenocarcinomas. Hum Pathol 2013; 44 (10) 2116-2125
  • 57 Airoldi M, Garzaro M, Valente G. et al. Clinical and biological prognostic factors in 179 cases with sinonasal carcinoma treated in the Italian Piedmont region. Oncology 2009; 76 (04) 262-269
  • 58 Lund VJ, Chisholm EJ, Takes RP. et al. Evidence for treatment strategies in sinonasal adenocarcinoma. Head Neck 2012; 34 (08) 1168-1178
  • 59 Podboj J, Smid L. Endoscopic surgery with curative intent for malignant tumors of the nose and paranasal sinuses. Eur J Surg Oncol 2007; 33 (09) 1081-1086
  • 60 Meccariello G, Deganello A, Choussy O. et al. Endoscopic nasal versus open approach for the management of sinonasal adenocarcinoma: a pooled-analysis of 1826 patients. Head Neck 2016; 38 (Suppl. 01) E2267-E2274
  • 61 Moreau JJ, Bessede JP, Heurtebise F. et al. Adenocarcinoma of the ethmoid sinus in woodworkers. Retrospective study of 25 cases [in French]. Neurochirurgie 1997; 43 (02) 111-117
  • 62 Bogaerts S, Vander Poorten V, Nuyts S, Van den Bogaert W, Jorissen M. Results of endoscopic resection followed by radiotherapy for primarily diagnosed adenocarcinomas of the paranasal sinuses. Head Neck 2008; 30 (06) 728-736
  • 63 Goffart Y, Jorissen M, Daele J. et al. Minimally invasive endoscopic management of malignant sinonasal tumours. Acta Otorhinolaryngol Belg 2000; 54 (02) 221-232
  • 64 Jardeleza C, Seiberling K, Floreani S, Wormald PJ. Surgical outcomes of endoscopic management of adenocarcinoma of the sinonasal cavity. Rhinology 2009; 47 (04) 354-361
  • 65 Lund V, Howard DJ, Wei WI. Endoscopic resection of malignant tumors of the nose and sinuses. Am J Rhinol 2007; 21 (01) 89-94
  • 66 Nicolai P, Battaglia P, Bignami M. et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol 2008; 22 (03) 308-316
  • 67 Van Gerven L, Jorissen M, Nuyts S, Hermans R, Vander Poorten V. Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy. Head Neck 2011; 33 (06) 898-904
  • 68 Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg 2009; 135 (12) 1219-1224
  • 69 Bussi M, Gervasio CF, Riontino E. et al. Study of ethmoidal mucosa in a population at occupational high risk of sinonasal adenocarcinoma. Acta Otolaryngol 2002; 122 (02) 197-201
  • 70 McKay SP, Shibuya TY, Armstrong WB. et al. Cell carcinoma of the paranasal sinuses and skull base. Am J Otolaryngol 2007; 28 (05) 294-301
  • 71 Vergez S, du Mayne MD, Coste A. et al. Multicenter study to assess endoscopic resection of 159 sinonasal adenocarcinomas. Ann Surg Oncol 2014; 21 (04) 1384-1390
  • 72 Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L. EUROCARE Working Group. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer 2015; 51 (15) 2130-2143